PRESUMED JOSEPH DISEASE - 3 NEW KINDREDS AND RESPONSE TO ANTI-PARKINSON DRUGS

被引:0
|
作者
SUBRAMONY, SH
CURRIER, RD
JACKSON, JF
COLLINS, GM
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:233 / 233
页数:1
相关论文
共 50 条
  • [1] Sleep attacks induced by anti-Parkinson disease drugs
    Miranda, M
    Díaz, V
    Venegas, P
    Villagra, R
    REVISTA MEDICA DE CHILE, 2001, 129 (05) : 585 - 586
  • [2] Anti-Parkinson's disease drugs and pharmacogenetic considerations
    Agundez, Jose A. G.
    Garcia-Martin, Elena
    Alonso-Navarro, Hortensia
    Javier Jimenez-Jimenez, Felix
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (07) : 859 - 874
  • [3] ANTI-PARKINSON DRUGS IN PARANOID SCHIZOPHRENIA
    CAVENAR, JO
    BRAASCH, ER
    SULLIVAN, JL
    NORTH CAROLINA MEDICAL JOURNAL, 1979, 40 (05) : 287 - 288
  • [4] ANTI-PARKINSON DRUGS AND OREXIN NEURONS
    Katsuki, Hiroshi
    Michinaga, Shotaro
    VITAMINS AND HORMONES: SLEEP HORMONES, VOL 89, 2012, 89 : 279 - 290
  • [5] Isostructural metabolites of two anti-Parkinson drugs
    Simon, K
    Harmat, V
    Torok, Z
    Bocskei, Z
    Hermecz, I
    ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY, 1998, 54 : 811 - 813
  • [6] The evolution of use of anti-Parkinson drugs in Spain
    Montané, E
    Vallano, A
    Castel, JM
    REVISTA DE NEUROLOGIA, 2002, 34 (07) : 612 - 617
  • [7] ABUSE OF THE ANTI-PARKINSON DRUGS - A REVIEW OF THE LITERATURE
    SMITH, JM
    JOURNAL OF CLINICAL PSYCHIATRY, 1980, 41 (10) : 351 - 354
  • [8] EFFECTS OF ANTI-PARKINSON DRUGS ON CORTICAL NEURONS
    CLARKE, G
    DAVIES, J
    BRITISH JOURNAL OF PHARMACOLOGY, 1973, 47 (03) : 465 - 475
  • [9] Determination of drugs used as anti-Parkinson's disease drugs in urine and serum by capillary electrophoresis
    Vargas, G
    Havel, J
    Babácková, L
    Patocka, J
    JOURNAL OF CAPILLARY ELECTROPHORESIS, 1998, 5 (3-4) : 153 - 158
  • [10] METABOLISM OF ANTI-PARKINSON DRUGS - EXAMPLE OF COMPETITIVE HYDROXYLATION
    STOCK, B
    SPITELLER, G
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1979, 29-1 (04): : 610 - 615